Kinder- und Jugendarztliche Gemeinschaftspraxis
- Address
- Anne-Frank-Str. 27, 75015 Bretten, Germany
Kinder- und Jugendarztliche Gemeinschaftspraxis - Pediatric Vaccine Research
This pediatric and adolescent medicine group practice specializes in vaccine immunogenicity and long-term protection studies in children and adolescents. The center focuses on evaluating the effectiveness and safety of preventive vaccines across different age groups, with particular expertise in tracking immune responses over extended follow-up periods.
- Long-term vaccine immunity and booster response evaluation in pediatric populations
- Meningococcal conjugate vaccine research and disease prevention
- Multi-year follow-up studies assessing vaccine persistence in children and adolescents
The practice demonstrates extensive experience in conducting international multicenter vaccine immunogenicity trials, particularly focusing on meningococcal infection prevention through conjugate vaccines. Their research methodology includes evaluating seroresponse sufficiency after primary vaccination and subsequent booster doses administered at 5- and 10-year intervals, providing critical data on optimal vaccination schedules for long-term protection in pediatric populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Kinder- und Jugendarztliche Gemeinschaftspraxis
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of MenACYW Conjugate Vaccine Booster in Pediatric and Adolescent Populations with Prior Vaccination | Sanofi Pasteur | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid | 1 | Unknown | 2022-08-23 | 2022-08-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.